INTRODUCTION
phloem . Upstream of CO, the photoreceptor cry2 also acts in the phloem to promote flowering in long days (Endo et al., 2007) . By contrast, phyB acts in mesophyll cells to inhibit the induction of flowering (Endo et al., 2005) . Thus, non-cellautonomous effects from both the phloem and the mesophyll operate to regulate photoperiodic flowering.
Micro-beam irradiation of cotyledons induces a light-responsive promoter also outside the irradiated areas, indicating intercellular communication in seedlings (Bischoff et al., 1997) . In Arabidopsis seedlings, expression of PHYB in cotyledon mesophyll complemented the hypocotyl-length phenotype of the phyB mutant (Endo et al., 2005) . Similarly, inhibiting phytochrome function specifically in cotyledon mesophyll resulted in elongation of the hypocotyl, indicating movement of a phytochrome-dependent signal from cotyledons to the hypocotyl (Warnasooriya and Montgomery, 2009) . Auxin biosynthesis and polar auxin transport are required for the increase in hypocotyl elongation in response to low R/FR irradiation, suggesting that auxin contributes to inter-organ communication (Keuskamp et al., 2010; Tao et al., 2008) . Consistent with this idea, the low R/FR signal is perceived by the leaf blade and led to increased elongation of the petiole via a process requiring polar auxin transport (Kozuka et al., 2010) . However, polar auxin transport was not required for hypocotyl elongation in dark-grown seedlings (Jensen et al., 1998) . By contrast, GA biosynthesis as well as normal cytokinin levels and auxin signaling are required for etiolation of seedlings in darkness (Alabadi et al., 2004; Reed et al., 1998) .
Thus far, the functions of light signaling intermediates have not been investigated at tissue resolution. We therefore examined whether SPA1, as a member of the COP1/SPA complex, participates in or induces non-cell-autonomous signaling events.
MATERIALS AND METHODS
Plant material and growth conditions spa1-7, spa3-1 spa4-1 and spa1-7 spa3-1 spa4-1 (Col), and spa1-2, phyB-1, spa1-2 phyB-1 (RLD) have been described previously (Fittinghoff et al., 2006; Hoecker et al., 1998; Parks et al., 2001) . spa1-7 spa2-1 spa3-1 and spa1-7 cry2-1 (Guo et al., 1998) were generated by crossing and confirmed using polymorphic markers and cry2 immunoblotting.
LED light sources, growth conditions and phenotype analyses have been described previously (Kang et al., 2009; Laubinger et al., 2004; Laubinger et al., 2006) .
Plasmid construction and genetic analysis of transgenic plants
To generate a GUS-SPA1 destination vector, polylinkers (NcoI-ApaI-SacI-NcoI and SalI-SacI-NotI-SalI) were inserted into the NcoI and SalI sites of pRTL2/GUS-SPA1 (Hoecker et al., 1999) . GUS-SPA1 was subsequently excised by partial SacI digestion and ligated into the SacI site of pGWB1 (Nakagawa et al., 2007) . The 2260 bp SPA1 promoter, the 1537 bp CAB3 promoter and the 1208 bp CER6 promoter (upstream of the respective coding region) were PCR amplified from Columbia genomic DNA and subsequently introduced into the pDONR221 vector (Invitrogen). All other promoter entry clones have been described previously . Promoter::GUS-SPA1 constructs were generated through LR reactions between the pGWB1/GUS-SPA1 and promoter entry clones and subsequently transformed into the spa1 spa2 spa3 and the spa1 spa3 spa4 mutants.
Determination of epidermis cell number and size
The fully expanded leaf three of 3-week-old plants was cleared in 95% ethanol followed by rehydration in a graded ethanol series. The average number of epidermis cells per leaf was calculated from the total leaf area, as determined by ImageJ (Bethesda, MA, USA), and the number of epidermis cells in a defined area of the leaf. Total leaf area and average number of epidermis cells in the leaf were used to calculate the average size of an epidermis cell. All error bars shown indicate the s.e.m.
Histochemical analysis of GUS activity
Whole tissues were vacuum-infiltrated in GUS-staining buffer [0.5 mM NaPO 4 (pH 7.0), 10 mM EDTA, 1 mM potassium ferrocyanide, 1 mM potassium ferricyanide, 1 mM 5-bromo-4-chloro-3-indolyl-b-d-glucuronic acid (X-Gluc) and 0.1% Triton X-100], incubated at 37°C and then destained in 70% ethanol.
Cross-sections of leaf and stem tissues were prepared using a razor blade followed by staining procedures as described above. For cross-sections of cotyledons, GUS-stained seedlings were fixed (50% ethanol, 5% acetic acid, 3% formaldehyde), dehydrated in a graded ethanol series (70%, 96% and 100%; 2 hours each), embedded in Technovit 7100 (Heraeus Kulzer) according to the manufacturer's instructions and sectioned using a microtome.
In situ hybridization
In situ hybridization followed the protocol of Jackson (Jackson, 1991) . Paraffin-embedded tissue was sectioned using a Leica RM2145 rotary microtome (7-10 m). SPA1 probes were obtained from nucleotides +63 to +430 relative to the start codon of the open reading frame and fused to the T7 promoter in sense and antisense orientations. Digoxigenin-labeled RNA probes were obtained as described previously (Bradley et al., 1993) .
RNA isolation and transcript analysis
RNA isolation and qRT-PCR were performed as described previously (Balcerowicz et al., 2011) . Primers for FT and UBQ10 amplification have been described previously (Endo et al., 2007; Balcerowicz et al., 2011) .
RESULTS

Spatial pattern of SPA1 accumulation in Arabidopsis
We first conducted a SPA1 RNA in situ analysis to determine which tissues express SPA1. SPA1 mRNA accumulated ubiquitously in seedlings and leaves ( Fig. 1A-J ). SPA1 transcript levels were particularly high in vascular tissue of dark-grown seedlings (Fig.  1C ). In developing leaves, SPA1 mRNA levels were lower in epidermal tissue than in inner tissues (Fig. 1I ). The spatial SPA1 transcript accumulation was very similar in the spa mutant backgrounds used in the studies described below (see Fig. S1 in the supplementary material). This ubiquitous expression pattern was also observed in transgenic plants expressing a GUS-SPA1 fusion protein under the control of the native SPA1 promoter (SPA1::GUS-SPA1) ( Fig. 1K-Z) . Here, we used two spa triple mutant backgrounds for transgene expression in order to be able to assess the functionality of the transgene throughout development, which is partly masked by redundancy among the four SPA genes. Transgenic lines showed full complementation of the spa1 spa2 spa3 triple mutant seedling phenotype and the spa1 spa3 spa4 mutant adult phenotype (leaf size and flowering time), respectively, indicating that the transgene was fully functional (Figs 3, 4, 8, 9, see also below) . In seedlings, GUS activity was higher in cotyledons and the root tip than in the hypocotyl ( Fig. 1K -O,Q-U). GUS-SPA1 accumulated in the epidermis, the mesophyll and -at particularly high levels -in vascular bundles ( Fig. 1M ,O,P,S,U,V). Also in adult plants, , with very strong expression in vascular bundles and lower expression in the epidermis (Fig. 1X,Y) . In stem vasculature, GUS-SPA1 was primarily expressed in the phloem (Fig. 1Z ).
Tissue-specific expression of GUS-SPA1 in transgenic spa1 spa3 spa4 plants
Adult spa1 spa3 spa4 mutants are very small in size and show extremely early flowering in short days when compared with wildtype plants (Laubinger et al., 2004; Laubinger et al., 2006) . We therefore used this background to investigate in which tissues SPA1
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Development 138 (9) acts to regulate photoperiodic flowering and leaf expansion. To this end, a GUS-SPA1 fusion protein was expressed under the control of tissue-specific promoters. Promoters used were pSUC2 for phloem-specificity (Stadler and Sauer, 1996; Truernit and Sauer, 1995) , pCAB3 for mesophyll-specificity (Susek et al., 1993) , pML1 and pCER6 for epidermis specificity (Hooker et al., 2002; Lu et al., 1996; Sessions et al., 1999) , pKNAT1 for shoot meristem specificity (Lincoln et al., 1994) and pTobRB7 for root specificity (Yamamoto et al., 1991) . Previously, these promoters have successfully been used to study photoperiodic flowering Endo et al., 2007) , seedling development (Endo et al., 2007; Savaldi-Goldstein et al., 2007; Warnasooriya and Montgomery, 2009 ) and other phenotypes such as shoot branching (Booker et al., 2003) . For each promoter::GUS-SPA1 construct, at least 40 independent transgenic lines were analyzed for tissue-specific expression and complementation of the spa mutant phenotype. Among these, three representative lines were propagated to obtain homozygous transgenic lines that are presented in Fig. 2 and Figs S2, S3 in the supplementary material. When expressed from the SUC2 promoter, GUS-SPA1 accumulated exclusively in vascular bundles ( Fig. 2A -E and see Figs S2, S3 in the supplementary material). GUS activity was highest in developed leaves and weaker, but detectable, in very young leaves (~2 mm length). Leaf primordia, by contrast, did not show detectable GUS-SPA1 expression (data not shown). Such stage-dependent activity of the SUC2 promoter has also been reported in previous studies (Imalu et al., 1999; Truernit and Sauer, 1995) .
In CAB3::GUS-SPA1 transgenic lines, GUS-SPA1 expression was restricted to mesophyll cells (Fig. 2F ,G and see Figs S2, S3 in the supplementary material). Exclusive expression of GUS-SPA1 in the epidermis was detected in ML1::GUS-SPA1 (Fig. 2H ,I and see Figs S2, S3 in the supplementary material) and CER6::GUS-SPA1 (Fig. 2J ,K and see Figs S2, S3 in the supplementary material) lines. The expression levels using both promoters, ML1 and CER6, were high at the shoot apex, in leaf primordia and in young developing leaves, and decreased to lower levels in developed leaves. KNAT1::GUS-SPA1 and TobRB7::GUS-SPA1 transgenic lines showed shoot meristem-and root-specific expression of GUS-SPA1, respectively (Fig. 2L ,M and see Figs S2, S3 in the supplementary material). In all transgenic lines, the levels of GUS-SPA1 in the respective tissues were either similar to or higher than those of GUS-SPA1 when expressed under the control of the native SPA1 promoter (Figs 1, 2) . RESEARCH ARTICLE SPA1 action in the phloem 
SPA1 acts in the phloem to regulate photoperiodic flowering
We examined in which tissues SPA1 acts to regulate flowering time. The spa1 spa3 spa4 triple mutant used for these experiments flowers very early in short days and slightly early in long days when compared with the wild type ( Fig. 3 and see Fig. S4A in the supplementary material) . Expression of GUS-SPA1 under the control of the native SPA1 promoter caused full complementation of the early-flowering phenotype of the spa1 spa3 spa4 triple mutant ( Fig. 3 ; see Fig. S4A in the supplementary material). Similarly, SUC2::GUS-SPA1 transgenic lines, which express GUS-SPA1 exclusively in the phloem, showed full complementation of the early-flowering phenotype of the parental spa triple mutant. By contrast, expression of GUS-SPA1 in any other tissue failed to rescue the spa triple mutant phenotype ( Fig. 3 and see Fig. S4A in the supplementary material). In summary, these data demonstrate that SPA1 expression in the phloem is sufficient to inhibit flowering. Consistent with this finding, phloem-specific expression of GUS-SPA1 reduced FT transcript levels (see Fig. S5 in the supplementary material).
SPA1 acts in phloem and mesophyll tissues to regulate leaf expansion
The spa3 spa4 double mutant, with functional SPA1, has larger leaves than the spa1 spa3 spa4 triple mutant, indicating that SPA1 plays a significant role in leaf expansion (Fittinghoff et al., 2006; Laubinger et al., 2004) (Fig. 4A,B ). We therefore analyzed this phenotype in transgenic spa1 spa3 spa4 plants expressing promoter::GUS-SPA1 constructs. As expected, transgenic SPA1::GUS-SPA1 lines showed full complementation of the leafsize phenotype of the parental spa triple mutant in short and long days ( Fig. 4A,B ; see Fig. S4B in the supplementary material). Phloem-specific as well as mesophyll-specific expression of GUS-SPA1 under the control of the SUC2 and CAB3 promoters, respectively, partially complemented the leaf-size phenotype of the spa triple mutant. By contrast, expression of GUS-SPA1 in the epidermis (ML1, CER6), the shoot meristem (KNAT1) or the root (TobRB7) failed to complement the spa mutant leaf-size phenotype. These data indicate that SPA1 acts in both the phloem and the leaf mesophyll to regulate leaf expansion.
Because leaves of the spa1 spa3 spa4 mutant contain fewer and smaller epidermal cells when compared with the wild type (P.F. and U.H., unpublished), we investigated whether expression of GUS-SPA1 rescued the cell division and/or cell expansion defect of epidermal cells. Fig. 4C ,D shows that GUS-SPA1 expression in phloem or mesophyll tissues led to an increase in the number and, more weakly, the size of leaf epidermal cells. By contrast, epidermis-specific expression of GUS-SPA1 did not affect the number or size of epidermal cells. These results show that SPA1 activity in phloem and mesophyll tissues regulates division and expansion of epidermal cells. This indicates that SPA1 influences the epidermis through non-cell-autonomous effects.
None of the tissue-specific promoters used was capable of fully rescuing the spa1 mutant leaf phenotype. This suggests that SPA1 expression in more than one tissue is necessary for full SPA1 function in the leaf. To test this possibility, we expressed SPA1 in both phloem and mesophyll tissues by crossing transgenic plants harboring the CAB3::GUS-SPA1 construct with those carrying the SUC2::GUS-SPA1 construct. Indeed, these double transgenic plants exhibited full complementation of the leaf-size phenotype of the parental spa triple mutant (Fig. 5A,B ).
Genetic interaction of SPA1 and photoreceptors in controlling photoperiodic flowering and leaf expansion
The photoreceptors phyB and cry2 have previously been shown to regulate photoperiodic flowering in a non-cell-autonomous fashion. cry2 acts in the phloem, whereas phyB acts in the mesophyll to regulate flowering time (Endo et al., 2007; Endo et al., 2005) . Additionally, phyB has been suggested to act in the mesophyll to regulate rosette leaf morphology (Endo et al., 2005) . We therefore investigated the epistatic relationship between SPA1 action and photoreceptor activity.
The spa1 cry2 double mutant flowered as early as the spa1 single mutant, indicating that spa1 is fully epistatic to cry2 (Fig.  6A,B ). This indicates that SPA1 acts genetically downstream of CRY2 in the same pathway. This result is consistent with the model that cry2 promotes flowering by inhibiting COP1/SPA ubiquitin 1855 RESEARCH ARTICLE SPA1 action in the phloem Fig. 3 . SPA1 acts in the phloem to regulate flowering time. Flowering time of short-day-grown transgenic plants expressing GUS-SPA1 in specific tissues of the spa1 spa3 spa4 mutant. For each transgene, several independent homozygous transgenic lines were analyzed, as indicated by the line numbers. Asterisks indicate significant differences between the indicated genotypes and the spa1 spa3 spa4 mutant (t-test, P<0.001). Data are mean±s.e.m. ligase activity (Liu et al., 2008) . spa1 and phyB single mutants flowered early in short days when compared with wild-type plants (Fig. 6C ). The spa1 phyB double mutant flowered even earlier than both single mutants, indicating that spa1 and phyB mutations act additively. This suggests that SPA1 and PHYB act in independent pathways to regulate photoperiodic flowering.
Leaves of the phyB mutant show constitutive shade avoidance, displaying smaller leaf blades and longer petioles when compared with leaves of wild-type plants (Reed et al., 1993) (Fig. 6D) . By contrast, leaves of the spa1 phyB double mutant did not exhibit a constitutive shade avoidance response. This indicates that the phyB mutation requires the presence of functional SPA1 to show the striking leaf phenotype and that spa1 is epistatic to phyB in the regulation of leaf morphology. Thus, here SPA1 acts downstream of PHYB in the same pathway.
Tissue-specific expression of GUS-SPA1 in transgenic spa1 spa2 spa3 seedlings
To express GUS-SPA1 in specific tissues of the seedling, the spa1 spa2 spa3 mutant background was used. This mutant shows constitutive photomorphogenesis in darkness, a phenotype that is not observed in the spa1 spa3 spa4 mutant used for the analysis of adult phenotypes (Laubinger et al., 2004) . We employed the same tissuespecific promoters as used for studying flowering time and leaf expansion, except for the CER6 promoter, which is not expressed in dark-grown seedlings (Hooker et al., 2002) . Additionally, pRolC was used as a phloem-specific promoter (Booker et al., 2003) in darkgrown seedlings because we found that pSUC2 failed to confer true phloem-specific expression in cotyledons of dark-grown seedlings that were more than 2 days old (data not shown).
Again, three representative transgenic lines were propagated to obtain homozygous lines which are shown in Fig. 7 and Figs S6, S7 in the supplementary material. The RolC promoter conferred vascular-specific expression of GUS-SPA1 in both dark-and lightgrown seedlings. We analyzed 4-day-old seedlings that had fully germinated (Fig. 7B,D; see Figs S6, S7 in the supplementary material), as well as seedlings that had just cracked the seed coat and thus had not yet initiated hypocotyl elongation (36 hours after the induction of germination; Fig. 7A ,C; see Figs S6, S7 in the supplementary material). At both stages, GUS activity was limited to the vasculature. In freshly imbibed seeds, by contrast, no GUS activity was detectable (data not shown). Transgenic SUC2::GUS-SPA1 lines also accumulated GUS specifically in the vasculature of light-grown seedlings (Fig. 7Q,R; see Figs S6, S7 in the supplementary material). The CAB3 and ML1 promoters conferred GUS-SPA1 expression specifically in the mesophyll and epidermis, respectively ( Fig. 7G-N; see Figs S6, S7 in the supplementary material). KNAT1::GUS-SPA1 and TobRB7::GUS-SPA1 transgenic lines showed shoot meristem-and root-specific expression of GUS-SPA1, respectively (Fig. 7E,F when compared with the SPA1 promoter. Exceptions are the CAB3 promoter in dark-grown seedlings and the RolC promoter in darkand light-grown seedlings, which caused lower levels of GUS-SPA1 accumulation than did the SPA1 promoter.
Expression of GUS-SPA1 in the phloem affects the development of dark-and light-grown seedlings
SPA1::GUS-SPA1 expression fully complemented the constitutive photomorphogenesis exhibited by dark-grown spa1 spa2 spa3 mutant seedlings (Fig. 8A,B ). Phloem-specific expression of GUS-SPA1 under the control of the RolC promoter mostly complemented the hypocotyl-length phenotype of the parental spa triple mutant in darkness. These transgenic seedlings displayed closed cotyledons but no apical hook. Epidermis-specific expression of GUS-SPA1 in ML1::GUS-SPA1 transgenic seedlings caused minor effects on hypocotyl elongation and partial cotyledon closure in darkness.
Mesophyll-specific expression of GUS-SPA1 (CAB3) also had a minor effect on hypocotyl elongation but no effect on the cotyledon phenotype. Meristem-and root-specific expression of GUS-SPA1 (KNAT1 and TobRB7, respectively) did not rescue any aspects of the spa triple mutant phenotype (Fig. 8A,B) .
When grown in weak red light, SPA1::GUS-SPA1 transgenic seedlings showed full complementation of the spa1 spa2 spa3 seedling phenotype. Phloem-specific expression of GUS-SPA1 (SUC2 or RolC) partially complemented the hypocotyl-length phenotype of the spa1 spa2 spa3 triple mutant (Fig. 8C,D) , which is in contrast to the almost full complementation observed in dark-grown seedlings (Fig. 8A,B) . In red light, SUC2 conferred a higher degree of complementation than RolC, which is consistent with the higher level of GUS-SPA1 accumulation in SUC2::GUS-SPA1 than in RolC::GUS-SPA1 seedlings (Fig.  7D,R) . Mesophyll-and epidermis-specific expression of GUS-SPA1 had slight effects on the spa1 spa2 spa3 mutant phenotype in red light. Neither shoot apical meristem-nor root-specific expression of GUS-SPA1 rescued the parental spa triple mutant phenotype (Fig. 8C,D) .
Taken together, these data show that expression of SPA1 in phloem tissues strongly promotes seedling etiolation, in particular in dark-grown seedlings. Because this result at first sight seemed surprising, we considered the possibility that undetectable GUS-SPA1 expression in non-phloem tissues causes the rescue of the spa mutant phenotype. However, as high-level GUS-SPA1 expression 1857 RESEARCH ARTICLE SPA1 action in the phloem in none of the other tissues, especially not in the mesophyll or epidermis, affected seedling growth of the spa mutant in a similarly strong fashion, we regard this possibility as extremely unlikely.
SPA1 acts in the phloem to suppress stomata and pavement cell differentiation in dark-grown seedlings
Full differentiation of stomata in cotyledons requires light and is dependent on photoreceptor function (Kang et al., 2009 ). cop1 and spa1 spa2 spa3 mutants differentiate stomata also in darkness and thus display constitutive photomorphogenesis also with respect to this phenotype (Kang et al., 2009) (Fig.  9A,B) . The differentiation of pavement cells in the epidermis is also suppressed in darkness through a SPA-dependent mechanism. Cotyledons of dark-grown wild-type seedlings showed small, non-lobed pavement cells, while cotyledons of the spa1 spa2 spa3 triple mutant exhibited large, multi-lobed pavement cells in darkness similar to wild-type seedlings grown in the light (Fig. 9A,B ; see Fig. S8 in the supplementary material).
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Development 138 (9) Fig. 8. SPA1 activity in the phloem alters the development of dark-and light-grown seedlings. (A,C)Visual phenotype 4-day-old seedlings grown in darkness (A) or weak Rc (0.1mol m -2 s -1 ) (C). Shown are the wild type (WT) and the spa1 spa2 spa3 mutant, as controls, and transgenic spa1 spa2 spa3 mutants expressing GUS-SPA1 under the control of the indicated promoters. For each transgene, three independent transgenic lines are shown. (B,D)Quantification of the hypocotyl length of seedlings grown in darkness (B) or weak Rc (0.1mol m -2 s -1 ) (D). Genotypes are as in A,C. Asterisks indicate significant differences between the indicated genotypes and the spa1 spa2 spa3 mutant (t-test, P<0.001). Data are mean±s.e.m.
SPA1::GUS-SPA1 transgenic lines showed arrested stomata development as well as non-lobed epidermal cells in cotyledons of dark-grown seedlings ( Fig. 9C ; see Fig. S8 in the supplementary material), indicating that SPA1 is sufficient to suppress stomata and pavement cell differentiation in the darkgrown spa1 spa2 spa3 mutant. RolC::GUS-SPA1 lines expressing GUS-SPA1 exclusively in the phloem also showed arrested stomata development and non-lobed epidermal cells in darkness ( Fig. 9D; see Fig. S8 in the supplementary material). Their epidermal cells appeared similar to those of dark-grown wild-type seedlings, with the exception that their pavement cells were larger than those of the wild type, but still smaller than those of the spa1 spa2 spa3 mutant.
Expression of GUS-SPA1 in epidermal cells (ML1) did not suppress stomata differentiation in the spa triple mutant ( Fig. 9E and see Fig. S8 in the supplementary material), even though the ML1 promoter is active in stomata (data not shown). This suggests that SPA1-dependent inhibition of stomata differentiation is not a cell-autonomous response. Shape and size of pavement cells, by contrast, was -in part -affected by SPA1 expression in the epidermis. These ML1::GUS-SPA1 transgenic lines exhibited smaller pavement cells with reduced lobing when compared with the parental spa triple mutant ( Fig. 9B,E ; see Fig. S8 in the supplementary material). Mesophyll-, meristem-or root-specific expression of GUS-SPA1 did not rescue the stomata or the pavement cell phenotype of the spa triple mutant progenitor ( Fig.  9F-H; see Fig. S8 in the supplementary material) .
DISCUSSION
Many light responses, such as seedling de-etiolation, shade avoidance and photoperiodic flowering, involve communication between different tissues or organs (Bou-Torrent et al., 2008; Josse et al., 2008; Montgomery, 2008) . A number of recent studies have elucidated the role of light-sensing photoreceptors in various tissues of Arabidopsis and have therefore provided an important framework in identifying photoreceptive sites for the light-induced regulation of plant growth and development (Endo et al., 2007; Endo et al., 2005; Warnasooriya and Montgomery, 2009 ). In which tissues light signaling proteins function has thus far not been investigated. Here, we have examined tissue-specific functions of a key repressor of light signaling, SPA1, which suppresses photomorphogenesis in darkness by ubiquitylation and subsequent degradation of activators of the light response (Hoecker, 2005) . To this end, we have expressed a GUS-SPA1 fusion protein under the control of tissue-specific promoters in transgenic plants. We show that SPA1 activity in phloem tissue of the vasculature controls seedling differentiation, leaf expansion and flowering time. Our results demonstrate that systemic signals are transmitted from the phloem to other tissues and, therefore, contribute to the coordinated growth of the different tissue layers in seedlings and leaves.
SPA1 acts in the phloem to control photoperiodic flowering
It has been known for a long time that photoperiodic stimuli are perceived by leaves and then transported via the phloem to the shoot apical meristem to induce the transition to flowering. Consistent with this observation, the photoreceptors cry2 and phyB were found to regulate flowering in the leaf and not in the shoot apical meristem. Interestingly, cry2 and phyB act in distinct tissues of the leaf: cry2 acts in the phloem, while phyB acts in the mesophyll to control flowering (Endo et al., 2007; Endo et al., 2005) . Here, we demonstrate that SPA1, like cry2, operates in the phloem, but not in the mesophyll, the epidermis or the shoot apical meristem, to regulate photoperiodic flowering. Moreover, spa1 was fully epistatic to cry2, indicating that SPA1 acts downstream of cry2 in the same signaling pathway. These results support the idea that light-activated cry2 inhibits the activity of the COP1/SPA complex in phloem cells (Liu et al., 2008) .
In contrast to cry2, phyB showed additive interactions with spa1 in flowering time control, suggesting that spa1 and phyB act in independent pathways. This is supported by recent evidence showing that red light and phyB control the degradation of CO via a COP1-independent mechanism (Jang et al., 2008) . The independent functions of SPA1 and phyB are also reflected by their sites of actions, which are different for SPA1 (phloem) and phyB (mesophyll) (Endo et al., 2005) .
It was recently shown that COP1, like SPA1, can act in the phloem to control flowering time, though other tissues have not been investigated (Jang et al., 2008) . Nevertheless, a function of the COP1/SPA1 complex in the phloem is reasonable because this complex controls flowering time by physically interacting with CO, which is expressed only in the vasculature and, moreover, is capable of operating only in the phloem among the tissues tested Jang et al., 2008; Laubinger et al., 2006; Liu et al., 2008) . Taken together, these results demonstrate that the COP1/SPA1 complex regulates CO stability cell-autonomously in phloem companion cells. Interestingly, the COP1/SPA complex also controls flowering time independently of CO as CO-deficient spa1 spa3 spa4 co and cop1 co mutants still exhibit a slight earlyflowering phenotype (P.F. and U.H., unpublished) (Jang et al.,
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RESEARCH ARTICLE SPA1 action in the phloem Fig. 9 . SPA1 acts in the phloem to suppress the differentiation of stomata and pavement cells in dark-grown seedlings. (A-H)Abaxial epidermis of cotyledons of dark-grown seedlings of the wild type (A), the spa1 spa2 spa3 mutant (B) and transgenic spa1 spa2 spa3 mutant lines carrying the constructs SPA1::GUS-SPA1 (line 5-2) (C), RolC::GUS-SPA1 (line 7-5) (D), ML1::GUS-SPA1 (line 6-1) (E), CAB3::GUS-SPA1 (line 13-1) (F), KNAT1::GUS-SPA1 (line 3-1) (G) and TobRB7::GUS-SPA1 (line 1-2) (H). Scale bars: 50m.
2008). Our finding that SPA1 acts in the phloem and not in other tissues, therefore, indicates that the CO-independent activities of SPA1 also operate in the phloem.
SPA1 is required in both phloem and mesophyll cells to allow normal leaf expansion
spa and cop1 mutants are very small plants that show strong defects in leaf expansion (Deng and Quail, 1992; Laubinger et al., 2004) . The spa mutant leaf phenotype was partially rescued when GUS-SPA1 was expressed in the phloem or in the mesophyll, whereas it was fully rescued when GUS-SPA1 was expressed in both of these tissues. This demonstrates that SPA1 activity in both tissues is necessary for normal leaf expansion. Expression of GUS-SPA1 in the epidermis, by contrast, did not rescue the spa mutant leaf phenotype, even though the epidermis-specific promoters used were expressed at even higher levels than the native SPA1 promoter, which expresses rather poorly in epidermal cells. This lack of SPA1 function in the epidermis is in contrast to brassinosteroid-mediated leaf expansion, which was shown to operate from the epidermis in a non-cell autonomous fashion (Savaldi-Goldstein et al., 2007) . Thus, SPA1-induced signaling and brassinosteroid signaling promote leaf expansion through distinct mechanisms.
SPA1 activity in phloem as well as mesophyll cells increased division and expansion of cells in the epidermal layer. This clearly shows that there are SPA1-dependent non-cell-autonomous signal(s) derived from the phloem and the mesophyll, which trigger cell division and expansion in the epidermis. In plants, some proteins have been reported to move from cell to cell via plasmodesmata (Lucas and Lee, 2004) . The SPA1 protein itself is not capable of movement because GUS activity in the GUS-SPA1 transgenic lines was not detected outside the expected expression domains. In addition, expression of GFP-SPA1 by particle bombardment never led to detectable GFP fluorescence in cells surrounding the transfected cell (data not shown). The constitutive nuclear localization of SPA1 would, moreover, most probably prevent movement of the protein (Hoecker et al., 1999) . Hence, we suggest that a downstream target of the COP1/SPA1 complex initiates a systemic activity.
Such a SPA1-induced systemic signal might involve changes in hormone levels because hormones have been shown to mediate light-controlled leaf expansion. For example, the reduced leaf growth associated with the shade avoidance syndrome is caused by an auxin-mediated increase in cytokinin oxidase expression that, interestingly, is primarily observed in the vasculature of developing leaves (Carabelli et al., 2007) . In addition, auxin-and brassinosteroid-responsive genes are upregulated in leaves in response to shade (Kozuka et al., 2010) . This is consistent with the observed increase in auxin levels via the TAA1 pathway in response to shade (Tao et al., 2008) . It will, therefore, be interesting to test whether SPA1 expression in the phloem and/or mesophyll affects hormone levels in the leaf.
The mobile signal(s) could originate from the phloem/mesophyll of the growing leaf or, in addition, from older already expanded leaves followed by transport to the young growing leaf. Signaling beyond a single organ was reported for the protein KLUH, which increases petal size beyond the individual petal (Eriksson et al., 2010) . Within an organ, non-cell-autonomous control of cell division was for example mediated by cell-to-cell movement of the cyclin-dependent kinase inhibitor ICK1/KRP1 (Weinl et al., 2005 ).
An alternative possibility is that physical forces generated by growth in SPA1-expressing phloem and/or mesophyll tissues drive cell division and expansion in the epidermis. The existence of such a mechanical stimulus is suggested by the finding that increased expression of the cell wall relaxation protein expansin promotes leaf growth (Sloan et al., 2009 ). In addition, local application of expansin to the shoot apical meristem could trigger local outgrowth (Fleming et al., 1997; Pien et al., 2001) .
Phloem-expressed SPA1 contributes to seedling etiolation in darkness and in the light
Our results show that expression of GUS-SPA1 in phloem tissue mostly complemented the constitutive photomorphogenesis of dark-grown spa mutant seedlings, while it partially rescued the spa mutant phenotype of light-grown seedlings. Thus, phloem tissue clearly provides a strong contribution to seedling differentiation. Phloem tissue may coordinate growth of surrounding tissue via physical forces and/or diffusible molecules, including hormones such as cytokinins, auxins or gibberellins (Nemhauser, 2008) .
The increased hypocotyl length in dark-grown seedlings solely results from enhanced cell elongation and does not involve cell division (Gendreau et al., 1997) . In this regard, it is noteworthy that root elongation via cell elongation requires DELLA signaling in the endodermis, an inner tissue surrounding the vascular bundles of the root. It has been shown that expression of the non-degradable DELLA protein GAI in the endodermis reduced cell elongation not only of endodermal cells but also of adjacent cortical and epidermal cells. By contrast, when GAI was targeted to other cells no effect on cell expansion was observed (Ubeda-Tomas et al., 2008) . Hence, the non-cellautonomous effect of phloem-expressed SPA1 on cell elongation in dark-grown seedlings might involve a similar mechanism, possibly physical force, as endodermis-expressed GAI.
Expression of GUS-SPA1 in mesophyll tissue of the cotyledon had only a very slight affect on the spa mutant phenotype in darkand in red light-grown seedlings, even though GUS-SPA1 was expressed at high levels at least in light-grown seedlings. This finding appeared surprising because it was shown previously that the phytochromes act in the mesophyll to control seedling deetiolation in the light (Endo et al., 2005; Warnasooriya and Montgomery, 2009) . Although, in darkness, no photoreceptors are active and principally different sites of action of SPA1 and the photoreceptors are conceivable, it is thought that in light-grown seedlings photoreceptors inactivate the COP1/SPA complex, possibly via direct physical interaction, to allow de-etiolation to occur. This would imply that photoreceptors and the COP1/SPA1 complex be active in the same cell. We therefore do not exclude the possibility that phytochromes and SPA1 act in both tissues, the phloem and the mesophyll. Thus, expression of SPA1 and phytochromes under the control of tissue-specific promoters/ enhancers might not fully reflect the endogenous level or timing of expression in the particular tissue and, therefore, might fail to complement the respective mutant phenotype. Alternatively, phytochrome action in the mesophyll of light-grown seedlings might cell-autonomously affect PIF proteins and not the COP1/SPA complex, at least with respect to seedling deetiolation. Active phytochromes were shown to initiate seedling de-etiolation by directly interacting with PIF proteins which are subsequently phosphorylated and degraded in a COP1independent fashion (Leivar and Quail, 2010) . In this scenario, Phytochrome-mediated reduction in COP1/SPA activity might not solely be a cell-autonomous action but might also involve cellcell communication between phytochrome in the mesophyll and SPA1 in the phloem. This communication might involve
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Development 138 (9) hormones such as gibberellins, which have been shown to control COP1 activity towards the substrate HY5 (Alabadi et al., 2008; Alabadi et al., 2004) . Interestingly, expression of the photoreceptor cry2 in the mesophyll did not rescue the cry2 mutant seedling phenotype, suggesting that phytochromes and cryptochromes act in different tissues of the seedling or, alternatively, that cry2 expression in additional tissues is required (Endo et al., 2007) . As cry2 is also thought to inactivate the COP1/SPA complex, it is likely that multiple mechanisms of light-induced seedling de-etiolation exist that might occur in different tissues of the seedling. In summary, we propose that seedling de-etiolation is a result of complex regulatory mechanisms involving mesophyll, phloem and, possibly, additional tissues.
Expression of GUS-SPA1 in the phloem was also sufficient to suppress stomata and pavement cell differentiation in epidermal cells of dark-grown seedlings. By contrast, expression of GUS-SPA1 in the epidermis did not alter stomata differentiation, but slightly affected pavement cell morphology. This indicates that SPA1 acts non-cell-autonomously in these responses. It has been shown previously that COP1 inhibits stomata differentiation upstream of the MAPKKK YDA and in parallel with the receptorlike protein TMM (Kang et al., 2009 ). The COP1/SPA complex might thus regulate stomata development through other receptorlike kinases, such as the ER family, or, alternatively, through hormonal (Saibo et al., 2003) or other thus far unknown mechanisms.
In summary, our results show that phloem tissue is a major site of action of SPA1. Consistent with this finding, SPA1 accumulates to particularly high levels in vascular tissue when compared with other tissues. Nevertheless, the SPA1 protein is expressed in most tissues of the seedling and the adult plant. This suggests that SPA1 has additional functions in these tissues that might be controlled in a cell-autonomous manner. Unraveling cell-autonomous and non cell-autonomous functions of SPA1, as well as of photoreceptors and other signaling intermediates will be an interesting endeavor in the future.
